Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Are insulin resistance and central adiposity associated with lower DHEA-S levels in women?

Insulin resistance and central adiposity are plausibly associated with lower DHEA-S in women, but the relationship depends strongly on menopausal stage.

PlausibleJune 19, 20268 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Insulin resistance and central adiposity are associated with lower DHEA-S levels in women in observational studies.

laying out figure…
0 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

Observational data show an inverse association between central adiposity/insulin resistance and circulating DHEA-S in premenopausal women, while postmenopausal cohorts often display the opposite pattern. Mechanistic evidence from adrenal cell studies supports plausibility: insulin can suppress SULT2A1 expression and thereby reduce DHEA sulfation to DHEA-S, linking hyperinsulinemia driven by visceral fat to lower DHEA-S levels.

Verified conclusion

The relationship between adrenal androgens, fat distribution, and metabolic health in women is complex and changes significantly across the lifespan. While cellular mechanisms suggest that insulin can suppress adrenal androgen production, clinical evidence reveals a highly stage-dependent relationship.

Clinical and epidemiological evidence

  • Premenopausal women: In younger, premenopausal cohorts, observational studies demonstrate an inverse correlation where higher endogenous DHEA levels are associated with lower visceral and central adiposity, suggesting a protective, anti-adipogenic role at the tissue level.
  • Postmenopausal women: This association reverses in late menopause. In postmenopausal women, higher DHEA-S levels are positively correlated with increased abdominal fat accumulation, indicating that the loss of ovarian estrogen alters how adrenal androgens affect adipose tissue distribution.
  • Insulin resistance associations: Epidemiological data indicate that DHEA-S does not independently predict insulin resistance or type 2 diabetes risk in women once adjustments are made for age, overall adiposity, and other circulating sex hormones.

Mechanistic explanations

  • SULT2A1 downregulation: In vitro studies in adrenocortical cells show that insulin exposure downregulates the transcription of the SULT2A1 gene. Because the SULT2A1 enzyme is responsible for sulfating DHEA into DHEA-S, this downregulation directly reduces DHEA-S synthesis and secretion.
  • Androgen interaction: Cellular models indicate that insulin acts synergistically to enhance testosterone's inhibitory effects on both DHEA-S and cortisol secretion in adrenal cells.
  • Adipose-insulin axis: Visceral adiposity functions as a primary driver of insulin resistance in women, which in turn can modulate adrenal steroidogenesis via the insulin-SULT2A1 pathway.

Bottom line

  • The association between central adiposity, insulin resistance, and lower DHEA-S levels is plausible but highly modified by menopausal status; a clear negative correlation exists in premenopausal women, whereas postmenopausal women show the opposite pattern.

References

  1. Effect of insulin and testosterone on androgen production and transcription of SULT2A1 in the NCI-H295R adrenocortical cell line. — pmc.ncbi.nlm.nih.gov ↗
  2. Regulation of the adrenal androgen biosynthesis — pmc.ncbi.nlm.nih.gov ↗
  3. The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. — academic.oup.com ↗
  4. Relationship of androgens to body composition, energy and substrate metabolism and aerobic capacity in healthy, young women — pmc.ncbi.nlm.nih.gov ↗
  5. The Relationship between Endogenous Androgens and Body Fat Distribution in Early and Late Postmenopausal Women — pmc.ncbi.nlm.nih.gov ↗
  6. Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women. — pmc.ncbi.nlm.nih.gov ↗
  7. Fat Distribution and its Correlation with Insulin Resistance, Androgen Markers, and Proinflammatory Cytokines in Polycystic Ovary Syndrome — thieme-connect.de ↗
  8. Abdominal Obesity in Women with Polycystic Ovary Syndrome and Its Relationship with Diet, Physical Activity and Insulin Resistance: A Pilot Study — mdpi.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→